Clorox Co (CLX) Shares Sold by Honkamp Krueger Financial Services Inc.

Honkamp Krueger Financial Services Inc. lowered its stake in Clorox Co (NYSE:CLX) by 37.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,811 shares of the company’s stock after selling 1,655 shares during the quarter. Honkamp Krueger Financial Services Inc.’s holdings in Clorox were worth $418,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Nicholas Hoffman & Company LLC. purchased a new stake in Clorox in the 4th quarter worth $201,000. Private Asset Management Inc. purchased a new stake in shares of Clorox during the 4th quarter valued at about $208,000. Lourd Capital LLC purchased a new stake in shares of Clorox during the 4th quarter valued at about $210,000. ZWJ Investment Counsel Inc. purchased a new stake in shares of Clorox during the 4th quarter valued at about $216,000. Finally, Northstar Investment Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter valued at about $222,000. Institutional investors and hedge funds own 75.77% of the company’s stock.

Shares of Clorox Co (NYSE:CLX) traded down $2.62 during trading hours on Wednesday, reaching $128.57. 720,370 shares of the company traded hands, compared to its average volume of 1,300,000. The company has a market cap of $16,640.00, a P/E ratio of 23.59, a price-to-earnings-growth ratio of 2.44 and a beta of 0.39. Clorox Co has a one year low of $124.09 and a one year high of $150.40. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Friday, February 2nd. The company reported $1.23 EPS for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.43 billion. Clorox had a net margin of 13.21% and a return on equity of 126.70%. The firm’s revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.14 EPS. analysts predict that Clorox Co will post 6.23 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, May 11th. Investors of record on Wednesday, April 25th will be issued a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a yield of 2.99%. This is an increase from Clorox’s previous quarterly dividend of $0.84. The ex-dividend date is Tuesday, April 24th. Clorox’s dividend payout ratio is presently 61.65%.

Several brokerages have recently issued reports on CLX. Deutsche Bank began coverage on shares of Clorox in a research report on Wednesday, December 13th. They set a “hold” rating and a $142.00 target price on the stock. BMO Capital Markets set a $147.00 target price on shares of Clorox and gave the company a “buy” rating in a research report on Monday, February 5th. Jefferies Group restated a “hold” rating and set a $130.00 target price on shares of Clorox in a research report on Wednesday, December 13th. Bank of America upgraded shares of Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 target price on the stock in a research report on Thursday, January 4th. Finally, Zacks Investment Research cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Monday, January 22nd. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company’s stock. Clorox presently has a consensus rating of “Hold” and a consensus target price of $132.61.

ILLEGAL ACTIVITY NOTICE: “Clorox Co (CLX) Shares Sold by Honkamp Krueger Financial Services Inc.” was published by Equities Focus and is owned by of Equities Focus. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.equitiesfocus.com/2018/03/14/honkamp-krueger-financial-services-inc-has-418000-stake-in-clorox-co-clx.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply